AstraZeneca completes sale of Aptium Oncology assets
6 July 2012 | By AstraZeneca
AstraZeneca has completed the previously indicated sale of the assets of its subsidiary, Aptium Oncology...
List view / Grid view
6 July 2012 | By AstraZeneca
AstraZeneca has completed the previously indicated sale of the assets of its subsidiary, Aptium Oncology...
5 July 2012 | By Boehringer Ingelheim
Joachim Hasenmaier to lead new Board Division Consumer Healthcare and Animal Health...
5 July 2012 | By Amgen
Amgen has announced the completion of the acquisition of KAI Pharmaceuticals, a privately held company based in South San Francisco...
5 July 2012 | By Biogen Idec
Biogen Idec and SOBI announced the initiation of two global pediatric clinical trials...
4 July 2012 | By Sanofi
"We are pleased to have been able to support the development of the Yves Rocher Group for about 40 years...”
CAMO Software & up to data have partnered...
3 July 2012 | By Abbott
Abbott has expanded its Healon® family of ophthalmic viscosurgical devices (OVDs)...
3 July 2012 | By HORIBA Scientific
HORIBA Scientific, organizes its first Technology Seminar focused on Life Sciences...
3 July 2012 | By FTI Consulting
The European Commission has adopted a legally binding decision in favour of granting of marketing authorisations for flutiform®...
2 July 2012 | By GlaxoSmithKline
Agreement reached with the US Government...
Lonza, a world leader in biopharmaceutical development technologies, announced today the addition of two new host organisms and their associated systems to its XS Technology™ Platform. The expanded XS Technology™ Toolbox addresses the diversity of microbially-derived proteins by providing complementary expression systems that quickly deliver simple, reliable, high yielding cGMP…
2 July 2012 | By Novo Nordisk
Novo Nordisk awarded the red dot Best of the Best prize for its next-generation insulin injection pen, the NovoPen® 5...
2 July 2012 | By GlaxoSmithKline
Results from the pivotal efficacy studies...
2 July 2012 | By TSI
The latest innovation in rapid microbiology method instrument technology is real-time viable detectors...
30 June 2012 | By AstraZeneca
Bristol-Myers Squibb to acquire Amylin...